Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 6, 2020 (6 years ago)

Desflurane

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Desflurane, USP Liquid for Inhalation, 240 mL, Rx Only, Manufactured by: Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, 200245, China for Sandoz Inc. Princeton, NJ 08540, NDC 0781-6172-22

Affected NDC 0781-6172-22

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Desflurane
NDC 00781-6172
240 mL/240mL Liquid
Respiratory (inhalation)
Sandoz Inc. Rx
Recalling firm
eVenus Pharmaceutical Laboratories
NDC code
0781-6172-22
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0042-2021 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other packaging defect recalls from 2020

All packaging defect recalls
Class II · Moderate risk

Levetiracetam Oral Solution

Defective container: Customer complaints for oral solution leaking from bottles.

Terminated Packaging defect Akorn, Inc. NDC 50383-241-16 D-0221-2021
Class II · Moderate risk

Childrens Dimetapp Cold & Cough

Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.

Terminated Packaging defect Glaxosmithkline Consumer Healthcare Holdings D-1362-2020